The Cancer Prevention Guide: What to Do for Each Major Cancer Type

Most cancer prevention advice is written at the level of general lifestyle: eat better, exercise more, don’t smoke. That advice is accurate but rarely specific enough to act on. What should you actually prioritize if you’re concerned about colorectal cancer specifically? Liver cancer? Breast cancer? The primary prevention strategies — and the magnitude of benefit available — differ substantially by cancer type.

This guide takes a different approach. Rather than organizing by prevention domain, it organizes by cancer type — addressing the ten most common and preventable cancers with the specific evidence-backed actions for each. Some of these cancers (cervical, liver, colorectal) have extraordinarily effective prevention tools that make them among the most avoidable diseases in medicine. Others (pancreatic) have fewer modifiable levers, but the ones that exist still matter.

The underlying reality is that 30–50% of all cancers are preventable through known modifiable risk factors (WHO/WCRF). For some specific cancer types, the preventable fraction is far higher. Understanding which prevention actions apply to which cancer type enables a genuinely informed, targeted approach to lifetime cancer risk.

Cancer Prevention at a Glance

1. Colorectal Cancer Prevention

Colorectal cancer (CRC) is one of the most preventable cancers — and uniquely, colonoscopy is the only cancer screening modality that is simultaneously diagnostic and preventive. Removing adenomatous polyps during colonoscopy prevents their transformation into cancer, rather than merely detecting it early.

Key prevention actions:

• Colonoscopy from age 45: Average-risk adults should begin at 45 (ACS 2018; USPSTF 2021). Alternatives: annual FIT, stool DNA test every 1–3 years, or CT colonography every 5 years.
• Dietary fiber 30g+/day: Meta-analyses show approximately 10% reduced CRC risk per additional 10g/day of fiber. Lentils, chickpeas, raspberries, and whole grains are practical sources.
• Limit red meat; eliminate processed meat: WCRF recommends ≤350–500g cooked red meat per week. Processed meat is IARC Group 1 for CRC — 50g/day increases risk by approximately 18%.
• Physical activity: Reduces colon cancer risk by approximately 20–24% through reduced colonic transit time, lower insulin, and reduced inflammation.
• Aspirin in Lynch syndrome: 600mg/day for ≥2 years reduced CRC incidence by ~50% (CAPP2 trial, Lancet 2011).

High-risk groups requiring enhanced surveillance:

• Lynch syndrome: Colonoscopy every 1–2 years from age 20–25; aspirin chemoprevention after discussion
• Familial adenomatous polyposis (FAP): Annual flexible sigmoidoscopy from 10–12; prophylactic colectomy in the teens
• Inflammatory bowel disease: Extensive UC: colonoscopy every 1–3 years after 8–10 years of disease

2. Breast Cancer Prevention

Breast cancer risk is substantially modifiable — and becomes even more manageable when genetic predisposition is identified and addressed appropriately.

• Regular physical activity: Associated with approximately 20–25% reduced postmenopausal breast cancer risk through reduced circulating estrogen, insulin, and inflammatory cytokines.
• Maintain healthy weight (especially postmenopausal): Adipose tissue aromatase drives ER-positive breast cancer. Each unit of excess BMI incrementally raises risk.
• Limit alcohol: Even one drink per day is associated with approximately 7–10% increased breast cancer risk in women. No safe threshold for breast cancer.
• Breastfeed if able: Approximately 4% reduced maternal breast cancer risk per year of cumulative breastfeeding (Collaborative Group, Lancet 2002).

Chemoprevention for high-risk women: Tamoxifen and raloxifene reduce breast cancer incidence by approximately 38–49% in high-risk women (USPSTF Grade B recommendation). Validated risk models (Tyrer-Cuzick, Gail) estimate individual 5-year risk.

BRCA1/2 carriers — specialized risk reduction:

• Annual breast MRI + mammography from age 25–30
• Risk-reducing salpingo-oophorectomy (RRSO): reduces ovarian cancer risk ~95%; reduces breast cancer risk ~50% for BRCA1 carriers when done premenopausally
• Risk-reducing mastectomy: reduces breast cancer risk by 90–95%

3. Cervical Cancer Prevention

Cervical cancer is one of the most preventable cancers in existence. The combination of HPV vaccination and regular screening can reduce cervical cancer incidence and mortality by over 90% in populations where both are consistently applied.

HPV vaccination: Gardasil 9 protects against HPV types 6, 11, 16, 18, 31, 33, 45, 52, and 58 — covering approximately 90% of HPV-attributable cancers. HPV 16 and 18 alone cause approximately 70% of cervical cancers. Recommended at ages 9–26, ideally at 11–12 before sexual debut; FDA-approved up to age 45 for eligible unvaccinated individuals. Also prevents oropharyngeal, vulvar, vaginal, anal, and penile cancers.

Cervical screening: Pap smear every 3 years from age 21; HPV co-testing every 5 years from age 30. Countries with universal HPV vaccination programs are already documenting dramatic reductions in cervical precancer in vaccinated cohorts.

4. Lung Cancer Prevention

Approximately 85% of lung cancer cases are attributable to tobacco smoking — making lung cancer the clearest example of a major cancer that is substantially preventable through a single behavioral change.

• Quit smoking: After 10 years of abstinence, former smokers have approximately 50% lower lung cancer risk than continuing smokers. Use combination therapy: varenicline + behavioral counseling produces the highest quit rates.
• Test your home for radon: Second-leading lung cancer cause in the US; ~21,000 deaths/year. Self-test kits cost $15–30. EPA action level: 4 pCi/L. Sub-slab depressurization reduces radon by 90%+.
• Avoid secondhand smoke: 20–30% increased lung cancer risk for non-smokers with regular exposures.
• Monitor air quality: PM2.5 is an IARC Group 1 carcinogen. Check air quality index; use HEPA air purifiers indoors.

Lung cancer screening: Annual low-dose CT (LDCT) for adults aged 50–80 with ≥20 pack-year smoking history who currently smoke or quit within 15 years — reduces lung cancer mortality by approximately 20% (NLST, N Engl J Med 2011).

5. Liver Cancer (HCC) Prevention

Hepatocellular carcinoma (HCC) is among the most preventable cancers through vaccination and treatment of viral hepatitis.

HBV vaccination: Prevents chronic HBV responsible for ~80% of HCC globally. Population-level programs have produced >70% reduction in HCC incidence in vaccinated birth cohorts (Chang MH et al., N Engl J Med 1997). Universal infant vaccination is recommended; unvaccinated adults should complete the series.

HCV treatment: Direct-acting antivirals achieve HCV cure in >95% of treated patients. Successful eradication reduces HCC risk by approximately 60–70%. Universal HCV screening is now recommended for all adults.

Additional prevention: Limit alcohol (reduces cirrhosis progression); manage weight (addresses MASH pathway to HCC); avoid aflatoxin B1 (IARC Group 1 liver carcinogen from moldy grain and nuts).

6. Stomach Cancer Prevention

Stomach cancer incidence varies dramatically by geography, largely due to H. pylori prevalence and dietary patterns.

H. pylori eradication: H. pylori is an IARC Group 1 carcinogen that causes most non-cardia gastric cancers through decades of progressive mucosal damage. Antibiotic-based eradication reduces gastric cancer risk by approximately 35%. Recommended testing and treatment for: immigrants from high-incidence countries, first-degree relatives of gastric cancer patients, unexplained iron deficiency, and chronic dyspepsia.

Dietary prevention: Limit salt-cured, smoked, and pickled foods (nitrosamines); increase vegetables and fruits, particularly vitamin C-rich foods that inhibit nitrosation.

CDH1/hereditary diffuse gastric cancer: Germline CDH1 mutations carry approximately 80% lifetime risk of diffuse gastric cancer. Prophylactic total gastrectomy is recommended for carriers after appropriate counseling — it eliminates gastric cancer risk in the context of near-inevitable malignancy.

7. Skin Cancer Prevention

Skin cancer is the most common cancer in the US and among the most directly preventable.

• SPF 30+ broad-spectrum sunscreen daily, 15–30 minutes before outdoor exposure, reapplied every 2 hours and after water exposure. Blocks approximately 97% of UVB.
• Protective clothing: long sleeves, wide-brim hat (≥3 inch brim), UV-blocking sunglasses
• Seek shade between 10am and 4pm when UV index peaks. UVA penetrates clouds and car windows — daily protection matters even on overcast days.
• Never use indoor tanning beds: IARC Group 1 carcinogens. Using one before age 35 increases melanoma risk by 59–75%.
• Annual full-body skin exam by a dermatologist for high-risk individuals (personal/family history of melanoma, numerous moles, chronic high UV exposure)

8. Endometrial Cancer Prevention

Endometrial cancer is the most common gynecologic cancer in the US — and its primary modifiable driver makes it one of the most directly preventable.

Weight management is the central prevention action: obesity accounts for an estimated 40% of endometrial cancer cases in developed countries through adipose aromatase-derived estrogen driving endometrial proliferation. A 5-unit BMI increase above normal increases risk by approximately 50%.

Physical activity reduces endometrial cancer risk by approximately 20–40% independently of weight.

Combined oral contraceptives reduce endometrial cancer risk by approximately 30–50%, with protection persisting years after discontinuation.

Lynch syndrome: Carriers face 40–60% lifetime endometrial cancer risk. Recommended: annual endometrial biopsy from age 30–35; risk-reducing hysterectomy + bilateral salpingo-oophorectomy is an option for women who have completed childbearing.

9. Prostate Cancer Prevention and Screening

Prostate cancer prevention has fewer high-certainty modifiable levers than many other cancer types, but diet, activity, and informed screening decisions carry meaningful evidence.

• Mediterranean diet pattern: epidemiological associations with lower prostate cancer risk, likely through anti-inflammatory pathways
• Lycopene/cooked tomatoes: consistent association with reduced prostate cancer risk; bioavailability increases with cooking in olive oil
• Finasteride/dutasteride: reduce prostate cancer incidence by approximately 25% (PCPT trial); discuss with physician for men at elevated risk
• PSA screening: shared decision-making from age 55 for average-risk men; earlier at 45–50 for Black men and those with first-degree relatives with prostate cancer. BRCA2 carriers face approximately 5–8× elevated risk and may benefit from earlier intensive surveillance.

10. Pancreatic Cancer — Reducing What You Can

Pancreatic cancer has limited early detection tools, but for individuals with relevant risk factors, available preventive actions are still meaningful.

• Quit tobacco: Smokers have approximately 2× the pancreatic cancer risk of non-smokers; risk falls with cessation.
• Manage weight and blood glucose: Obesity and long-standing type 2 diabetes are associated with elevated risk through hyperinsulinemia.
• Limit chronic heavy alcohol: Causes chronic pancreatitis — a recognized precursor to pancreatic cancer.

Hereditary surveillance: BRCA2 (~3.5–5×), PALB2 (~3×), ATM (~2×), Lynch syndrome (~2×), and Peutz-Jeghers syndrome (~130×) significantly elevate risk. Annual endoscopic ultrasound (EUS) and MRCP surveillance through a familial pancreatic cancer program can detect cystic precursor lesions. Refer individuals with multiple affected first-degree relatives to a structured familial surveillance program.

Frequently Asked Questions